Pivotal Response Treatment Package for Young Children With Autism
Trial ID or NCT#
NCT02037022
Status
NOT RECRUITING
Purpose
This is a research study examining the effectiveness of a pivotal response treatment package (PRT-P) in targeting language skills in young children with autism.
Official Title
Pivotal Response Treatment Package for Young Children With Autism
Eligibility Criteria
Ages Eligible for Study: 2 Years to 5 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- * Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview- Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS-2), and expert clinical opinion* Males and females in good medical health between 2.0 and 5.11 years* Ability to participate in the testing procedures to the extent that valid standard scores can be obtained* Language delay as measured by the Preschool Language Scale: Standard score at least 1 Standard Deviation below average for expressive language ability* Stable treatment, speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation* No more than 60 minutes of individual 1:1 speech therapy per week* Availability of at least one parent who can consistently participate in parent training and research measures* Parents intend on continuing Pivotal Response Treatment Package (PRT-P) for a minimum of 12 weeks* Parents must be 18 years of age or older
Exclusion Criteria:
- * Current or lifetime diagnosis of severe psychiatric disorder, such as bipolar disorder* Receiving in-home Applied Behavior Analysis (ABA) of 10 hours or more* A genetic abnormality, such as Fragile X* Presence of active medical problem, such as unstable seizure disorder or heart disease* Previous adequate PRT trial* Participants living more than 50 miles from Stanford University* At least one room of the house must be available to be dedicated to treatment during session times* There must be no serious health and safety risks present in the home environment* The research team has the right to refuse to perform sessions in-home even if the criteria above are met
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Rachel Schuck, BA
650-736-1235
View on ClinicalTrials.gov
